Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results
K. Daenens, et al., 20091
University Hospital Gasthuisberg, Belgium
Primary patency of GORE® PROPATEN® Vascular Graft
![N=86](/sites/default/files/styles/max_750x750/public/2019-06/n-86.gif.webp?itok=n7Sp5L7u)
![1 year 92%](/sites/default/files/styles/max_750x750/public/2019-06/samson-2.gif.webp?itok=qLC6DbHt)
![2 years 83%](/sites/default/files/styles/max_750x750/public/2019-06/2-year-83.gif.webp?itok=TjgQZoy8)
Patient characteristics*
Characteristic | N | % |
---|---|---|
Rutherford classification | ||
3 | 63 | 26% |
4 | 60 | 25% |
5 | 84 | 35% |
6 | 17 | 7% |
Smokers | 149 | 62% |
Redo bypass | 86 | 36% |
Study details
- Retrospective, non-randomized, single-center study
- Study compared results from GORE® PROPATEN® Vascular Graft to autologous vein bypasses
- The 1 and 2 year primary patency rates for above-knee fem-pop bypasses using autologous vein were 91% and 80%, respectively
Overall, our results...provide solid additional evidence that heparin-bonded ePTFE grafts represent an important new option in the treatment of peripheral arterial disease. – K. Daenens
*GORE® PROPATEN® Vascular Graft group, N = 240
1. Daenens K, Schepers S, Fourneau I, Houthoofd S, Nevelsteen A. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results. Journal of Vascular Surgery 2009;49(5):1210-1216.